The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

In vitro cytotoxicity studies were performed in MCF-7, Molt-4, and rhabdomyosarcoma cell lines. Feasibility and pharmacokinetic studies were performed in nonhuman primates. These preclinical studies ...

-Publication shows picomolar affinity for CCR8 with no off-target binding and proof-of- mechanism in preclinical and clinical studies- -Data show CCR8 target is present with high prevalence and ...

Numerous studies have documented that adolescents and young adults (AYAs) experience a significant cancer burden as well as significant cancer mortality compared with other age groups. The reasons for ...

CCR8 is highly expressed on immunosuppressive regulatory T cells (Tregs) in various solid tumors, making it a potential target to enhance antitumor immunity and the efficacy of cancer therapies, ...

This Research Topic is part of the Insights in Experimental Pharmacology and Drug Discovery series. You can explore the ...

PRINCETON, N.J.--(BUSINESS WIRE)--Certara®, the global leader in model-informed drug development and regulatory science, today announced the launch of its Quantitative Systems Pharmacology (QSP) ...

Cancer is a multifactorial disease, and its genesis and progression are extremely complex. The scope of precision oncology is rapidly expanding to address previously undruggable targets. The term ...

Please provide your email address to receive an email when new articles are posted on . James Turkson, PhD, has been named director for diversity, inclusion and strategy at Cedars-Sinai Cancer.

The positions in the table below reflect the Experimental Pharmacology and Oncology Berlin-Buch GmbH (EPO)'s position overall, domestically, within their sector, and in various subject areas based on ...